** Shares of Genetic Signatures GSS.AX down as much as 4.6% at its record low level of A$0.21
** The molecular diagnostics firm posts Q2 FY26, sales of A$3.3 million ($2.22 million), down from A$3.8 million a year ago
** About 422,306 shares change hands, 3.7x 30-day average
** Stock fell 60.3% in 2025
($1 = 1.4857 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.